Skip to main content
. 2016 Jul 21;100(6):1395–1404. doi: 10.1189/jlb.3A0316-125R

Figure 2. Effects of Dex are specific and are consistent with peritoneal MCs.

Figure 2.

(A) BMMCs were treated with RU-486 (0.5 µM) for 1 h before IL-33 (50 ng/ml) and Dex (0.1 µM) were added. Supernatants collected 6 h after activation were analyzed by ELISA. (B) Supernatants obtained from murine peritoneal MCs activated with IL-33 (50 ng/ml) and simultaneously treated with vehicle or Dex (1 µM) for 6 h were analyzed by ELISA. Data shown are representative of 3 independent experiments performed in triplicate. Tukey’s multiple-comparison test was used to calculate the P-values. ****P < 0.0001.